3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Dermatologic
5
Sarcoma
1
Gastrointestinal
1
Conditions
Sarcoma
19
Neoplasms
7
Osteosarcoma
5
Gastrointestinal Stromal Tumors
4
Neuroblastoma
3
Melanoma
3
Uterine Cervical Neoplasms
2
Testicular Neoplasms
2
Prostatic Neoplasms
2
Neoplasm Metastasis
2
Lymphoma
2
Lung Neoplasms
2
Glioma
2
Esophageal Neoplasms
2
Desmoid Tumors
2
Colonic Neoplasms
2
Carcinoma, Renal Cell
2
Breast Neoplasms
2
Brain Neoplasms
2
Wilms Tumor
1
Uveal Melanoma
1
Urinary Bladder Neoplasms
1
Stomach Neoplasms
1
Somatostatinoma
1
Skin Neoplasms
1
Sarcoma, Myeloid
1
Sarcoma, Ewing
1
Pancreatic Neoplasms
1
Oligodendroglioma
1
Neoplastic Cells, Circulating
1
Interventions
Cyclophosphamide
3
tislelizumab
1
spartalizumab
1
pembrolizumab
1
montanide ISA 51
1
entinostat
1
Thrombopoietin
1
LY2940680
1
Interleukin-2
1
Immunologic Techniques
1
Imatinib Mesylate
1
Ifosfamide
1
Granulocyte Colony-Stimulating Factor
1
Filgrastim
1
Etoposide
1
Cryosurgery
1
Carboplatin
1
Blood Specimen Collection
1
Bevacizumab
1
130-nm albumin-bound paclitaxel
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Uveal Melanoma
×
Blood Specimen Collection
×
Sarcoma
×
Clear all
NCT01046487
2026-03-13
PALANGI3
Centre Oscar Lambret
Phase 1
Completed
26 enrolled